Page last updated: 2024-08-21

oxazoles and Lung Diseases, Obstructive

oxazoles has been researched along with Lung Diseases, Obstructive in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bründler, H; Godly, R; Herzog, H; Imhof, E; Perruchoud, AP1
Cafaggi, R; D'Onofrio, V; Giosuè, S; Guerrini, P; Perrone, N; Scano, M1
Casali, L; Colombo, ML; Manazza, P; Rossi, A; Zoia, MC1

Trials

2 trial(s) available for oxazoles and Lung Diseases, Obstructive

ArticleYear
Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
    Respiration; international review of thoracic diseases, 1987, Volume: 51, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Double-Blind Method; Female; Hemodynamics; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Random Allocation; Respiratory Function Tests

1987
A comparison of the bronchodilator effects of broxaterol and salbutamol.
    International journal of clinical pharmacology, therapy, and toxicology, 1988, Volume: 26, Issue:2

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Blood Pressure; Bronchodilator Agents; Female; Heart Rate; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Respiratory Function Tests; Time Factors

1988

Other Studies

1 other study(ies) available for oxazoles and Lung Diseases, Obstructive

ArticleYear
[Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    La Clinica terapeutica, 1987, Apr-15, Volume: 121, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Female; Forced Expiratory Volume; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Vital Capacity

1987